Ï㽶ÊÓƵ

A study conducted at the Lady Davis Institute at the Jewish General Hospital revealed that pioglitazone is associated with a risk of bladder cancer that increases with duration of use and dosage.

Classified as: epidemiology, Oncology, Laurent Azoulay, Lady Davis Institute (LDI), health and lifestyle, blood sugar, pioglitazone, bladder cancer, rosiglitazone, thiazolidinediones
Published on: 31 Mar 2016

Landmark Clinical Trial of a Novel Combination Treatment for Type 1 Diabetes Begins at Jewish General Hospital and Ï㽶ÊÓƵ Health Centre

Classified as: muhc, jewish general hospital, diabetes, insulin, Ï㽶ÊÓƵ Health Centre, health and lifestyle, blood sugar, glucose, type 1, beta cells, EVMS, Jerry Nadler, INGAP peptide
Published on: 25 Nov 2015
Back to top